
Retail technology venture fund backing startups that help retailers adapt

Venture firm backing data-enabled companies where genomics, digital data and health care meet

Biomatics Capital Partners is a for-profit venture firm that invests where health care meets technology. It believes genomics combined with digital data is opening the way to better therapeutics, diagnostics and delivery models.
The firm works with founders creating a new generation of health care companies, in areas that range from gene editing to DNA synthesis. A founder quoted on its site says the team helped launch a company called Alairion. Its stated view is that advances in science are moving medicine towards a value-based system with lower costs and better outcomes for patients.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Biomatics Capital Partners is ranked on 1 TrustList ranking at #14.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Biomatics Capital Partners has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
Of the 30 here, 8 also cover seed stage and 8 also cover partners; 6 also work in Silicon Valley and 5 also work in New York City.
Behind Assurant Ventures, ahead of E8 Angels.
As of 2026-11-03. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Biomatics Capital Partners.
Similar listings buyers compare against this one.

Retail technology venture fund backing startups that help retailers adapt

Private equity firm making long-term control investments in middle market companies undergoing change

Swiss-based private mining and metals group producing nickel and ferronickel

Belgian seed and early-stage fund run by entrepreneurs, with a coaching programme for its startups

Early-stage investor run by four entrepreneurs backing European startup teams

Copenhagen-based life science investor that holds the Novo Group and manages the Novo Nordisk Foundation's assets

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Corporate venture arm of an energy company investing in high-growth energy and mobility technology businesses
Everything here links back to the same verified catalogue. Pick your next stop.